Fcmalt 1000 mg/ 20 ml Injection 1's

Fcmalt 1000 mg/ 20 ml Injection 1's belongs to the group of anti-anaemic medicines used to treat iron deficiency anaemia in patients who are intolerant to oral iron preparations, have non-dialysis dependant chronic kidney disease, or require a quick build-up of iron stores. Iron deficiency anaemia (lack of red blood cells caused by too little iron in the body) is a condition in which the body does not have enough red blood cells for carrying adequate oxygen to various body tissues.
 
Fcmalt 1000 mg/ 20 ml Injection 1's contains ‘ferric carboxymaltose’, which acts as a source of iron and helps in the transportation of oxygen throughout the body and the production of red blood cells. Thereby, Fcmalt 1000 mg/ 20 ml Injection 1's helps in treating anaemia. Fcmalt 1000 mg/ 20 ml Injection 1's helps various vital processes in the body.
 
Fcmalt 1000 mg/ 20 ml Injection 1's will be administered by a healthcare professional; do not self-administer. In some cases, you may experience certain common side effects such as nausea, flushing, dizziness, high blood pressure, and low levels of phosphorus in the blood. Most of these side effects do not require medical attention and will resolve gradually over time. However, you are advised to talk to your doctor if you experience these side effects persistently.
 
Let your doctor know if you are taking any prescription, non-prescription drugs, or herbal products before starting Fcmalt 1000 mg/ 20 ml Injection 1's. If you are known to be allergic to any of the components in Fcmalt 1000 mg/ 20 ml Injection 1's, please inform your doctor. Consult a doctor before taking Fcmalt 1000 mg/ 20 ml Injection 1's if you are pregnant or breastfeeding. Fcmalt 1000 mg/ 20 ml Injection 1's is not recommended for children below 14 years as safety and effectiveness have not been established.

Fcmalt 1000 mg/ 20 ml Injection 1's belongs to the group of anti-anaemic medicines used to treat iron deficiency anaemia in patients who are intolerant to oral iron preparations and have non-dialysis dependant chronic kidney disease. Fcmalt 1000 mg/ 20 ml Injection 1's contains ‘ferric carboxymaltose’, which acts as a source of iron and helps in the transportation of oxygen throughout the body and the production of red blood cells. Thereby, Fcmalt 1000 mg/ 20 ml Injection 1's helps in treating anaemia. Iron is necessary for various vital processes in the body.

Do not take Fcmalt 1000 mg/ 20 ml Injection 1's if you are allergic to any of its components, if you have anaemia not caused by iron deficiency, iron overload (excess iron in the body), or disturbances in iron utilisation. Inform your doctor if you have systemic lupus erythematosus, rheumatoid arthritis, severe asthma, eczema, infection, low phosphorus levels, high blood pressure, kidney or liver problems. Consult your doctor if you are pregnant or breastfeeding. Fcmalt 1000 mg/ 20 ml Injection 1's is not recommended for children below 14 years as safety and effectiveness have not been established. Let your doctor know if you are taking any prescription, non-prescription drugs, or herbal products before starting Fcmalt 1000 mg/ 20 ml Injection 1's.

• Regular monitoring of blood pressure and phosphorus levels whilst on treatment with Fcmalt 1000 mg/ 20 ml Injection 1's is advised.
• Fcmalt 1000 mg/ 20 ml Injection 1's might cause blackening/darkening of the stools and can interfere with test results. Inform the person doing the tests that you are taking Fcmalt 1000 mg/ 20 ml Injection 1's if you are having tests on your stools.
• Regular blood tests while taking Fcmalt 1000 mg/ 20 ml Injection 1's are advised.